Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer

被引:0
|
作者
Saitoh, G
Sugio, K
Ishida, T
Sugimachi, K
机构
[1] Atom Bomb Survivors Hosp, Naka Ku, Hiroshima 7308619, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan
关键词
p21(waf1); cyclin D1; retinoblastoma; immunohistochemistry; non-small cell lung cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p21(waf1) is a downstream effector of p53, and mediates growth arrest by inhibiting the action of G1 cyclin-dependent kinases. Cyclin D1 is a cell-cycle regulator essential for G1 phases progression and a candidate proto-oncogene implicated in the pathogenesis of several human tumor types. Cyclin D1 overexpression and the absence of retinoblastoma (Rb) protein have been frequently seen in various types of cancer, including lung cancer. The aim of this study was to clarify the relationship between the expressions of p21(waf1), cyclin D1, and Rb protein, and to investigate the correlation between these protein expressions and the clinical features of the patients, and their prognoses. We immunohistochemically examined 92 samples of resected non-small cell lung cancer for p21(waf1) cyclin D1, and Rb expression. Of the 92 specimens examined, 43 cases (46.7%) showed p21(waf1) expression, 23 cases (25.0%) showed cyclin D1 overexpression, and 61 cases (66.3%) showed Rb expression. No correlation was observed between the expressions of p21(waf1), cyclin D1, and Rb. There was no association of p21(waf1) and cyclin D1 immunoreactivity with gender, disease stage, or histological types of the tumor. Regarding the prognosis in 79 cases with complete resection, no statistical differences were observed according to the degree of expression of these three factors. However, when unfavorable prognostic factors were considered to be the positive expression of p21(waf1), positive of cyclin D1, and negative of Rb, the 5-year disease-free survival rate in the group with 2 or 3 unfavorable prognostic factors was 21.1%, which was statistically poorer than the 45.4% in the group with 0 or 1 unfavorable prognostic factor (p=0.0138). We conclude that examination of the expression of cell cycle regulators, such as p21(waf1), cyclin D1, and Rb, is useful as a prognostic indicator, when these proteins' expression is analyzed in combination.
引用
收藏
页码:737 / 743
页数:7
相关论文
共 50 条
  • [21] Cyclin D1 polymorphism in non-small cell lung cancer in a Portuguese population
    Catarino, R.
    Coelho, A.
    Nogueira, A.
    Araujo, A.
    Gomes, M.
    Lopes, C.
    Medeiros, R.
    CANCER BIOMARKERS, 2012, 12 (02) : 65 - 72
  • [22] Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II
    Jin, ML
    Inoue, S
    Umemura, T
    Moriya, J
    Arakawa, M
    Nagashima, K
    Kato, H
    LUNG CANCER, 2001, 34 (02) : 207 - 218
  • [23] p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer
    Vonlanthen, S
    Heighway, J
    Kappeler, A
    Altermatt, HJ
    Borner, MM
    Betticher, DC
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (05) : 951 - 957
  • [24] The prognostic significance of p53, p21(Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients
    Hirai, T
    Kuwahara, M
    Yoshida, K
    Osaki, A
    Toge, T
    ANTICANCER RESEARCH, 1999, 19 (5C) : 4587 - 4591
  • [25] Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas
    Xie, X
    Clausen, OPF
    Boysen, M
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (08) : 897 - 902
  • [26] Changes in expression of pRb, p16 and cyclin D1 in non-small cell lung cancer: an immunohistochemical study
    Malusecka, E
    Zborek, A
    Krzyzowska-Gruca, S
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 1999, 37 (01) : 19 - 24
  • [27] Prognostic significance of CYFRA 21-1 in non-small cell lung cancer
    Hirashima, T
    Takada, M
    Komiya, T
    Nitta, T
    Masashi, K
    Masuda, N
    Matui, K
    Kikui, M
    Yasumitsu, T
    Kawase, I
    ANTICANCER RESEARCH, 1998, 18 (6B) : 4713 - 4716
  • [28] Prognostic role of cyclin D1 in non small cell lung cancer: An immunohistochemical analysis
    Caputi, M
    DeLuca, L
    Papaccio, G
    DAponte, A
    Cavallotti, I
    Scala, P
    Scarano, F
    Manna, M
    Gualdiero, L
    DeLuca, B
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1997, 41 (02): : 133 - 138
  • [29] The effect of sulforaphane on the cell cycle, apoptosis and expression of cyclin D1 and p21 in the A549 non-small cell lung cancer cell line
    Zuryn, Agnieszka
    Litwiniec, Anna
    Safiejko-Mroczka, Barbara
    Klimaszewska-Wisniewska, Anna
    Gagat, Maciej
    Krajewski, Adrian
    Gackowska, Lidia
    Grzanka, Dariusz
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (06) : 2521 - 2533
  • [30] P21WAF1/CIP1 and p53 protein expression in non-small-cell lung cancer (NSCLC)
    Dworakowska, D
    Jassem, E
    Jassem, J
    Boltze, C
    Wiedorn, KH
    Karmolinski, A
    Dworakowski, R
    Lapinski, M
    Tomaszewski, D
    Skokowski, J
    Jaskiewicz, K
    Czestochowska, E
    LUNG CANCER, 2004, 45 : S31 - S31